Scleroderma. A case presentation

被引：0
|
作者：
Bembibre Taboada, Ruben [1 ]
Alvarado Borges, Annia [2 ]
Galende Hernandez, Niurka [3 ]
Cortizo Hernandez, Julio [3 ]
机构：
[1] Hosp Univ Dr Gustavo Aldereguia Lima Cienfuegos, Serv Terapia Intens Clin, Med Interna Med Intens & Emergencias, Cienfuegos, Cuba
[2] Hosp Univ Dr Gustavo Aldereguia Lima Cienfuegos, Anat Patol, Cienfuegos, Cuba
[3] Hosp Univ Dr Gustavo Aldereguia Lima, Tereia Intens, Cienfuegos, Cuba
来源：
MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS | 2005年 / 3卷 / 02期
关键词：
Systemic scleroderma;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This article presents a brief review about generalized sclerosis (sclerodermia) and reports a case with such disease talking into consideration that the patient received clinical intensive care assistaance and had a clinical diagnosis supoported by lab test for a clinical and differential diagnosis. Medical treatment was applied for the disease and for the possible complications, but the patients follow up was wrong due to multi organ failure as a consequence of derlying disease.
引用
收藏
页码：48 / 50
页数：3
相关论文
共 50 条
  • [31] HLA and the mutual exclusivity of autoantibodies in scleroderma.
    Fanning, GC
    Bunn, C
    Welsh, KI
    Black, CM
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1220 - 1220
  • [32] Antibody mediated gastrointestinal dysmotility in scleroderma.
    Goldblatt, FM
    Gordon, TP
    Waterman, SA
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S178 - S178
  • [33] Evaluation and management of pulmonary fibrosis in scleroderma.
    White B.
    Current Rheumatology Reports, 2002, 4 (2) : 108 - 112
  • [34] Evaluation of gastric function in patients with scleroderma.
    Garrigues, V
    Nos, P
    Ponce, J
    Sopena, R
    Cano, MC
    Caballero, F
    Berenguer, J
    GASTROENTEROLOGY, 1997, 112 (04) : A735 - A735
  • [35] Intestinal perforation: A common complication of scleroderma.
    Ebert, EC
    Ruggiero, FM
    Seibold, JR
    GASTROENTEROLOGY, 1996, 110 (04) : A14 - A14
  • [36] Open label trial of tamoxifen in scleroderma.
    Hoffman, GS
    Thomas, CK
    Wilke, WS
    Fessler, B
    Mandell, BF
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S330 - S330
  • [37] Orofacial manifestations of scleroderma. A literature review
    Said, M. Hadj
    Foletti, J. M.
    Graillon, N.
    Guyot, L.
    Chossegros, C.
    REVUE DE STOMATOLOGIE DE CHIRURGIE MAXILLO-FACIALE ET DE CHIRURGIE ORALE, 2016, 117 (05) : 322 - 326
  • [38] Validation of Vesmeter As a Diagnostic Tool of Scleroderma.
    Hishitani, Yoshihiro
    Shima, Yoshihito
    Tanaka, Toshio
    Kumanogoh, Atsushi
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S747 - S747
  • [39] Atypical serologies in a child with systemic scleroderma.
    Ryan, WM
    Arkachaisri, T
    O'Neil, KM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S124 - S124
  • [40] Apoptosis and proliferation of fibroblasts and inflammatory cells in scleroderma.
    Pablos, JL
    Carreira, PE
    Ballestin, C
    GomezReino, JJ
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1236 - 1236
12345